included (2 lymph node biopsy specimens, 5 aqueous humors). Overall, 76 samples from 56 patients 144 were analyzed. Clinical and biological data of the patients are detailed in Table 1.  145   146 Lack of impact of storage on qPCR Ct 147 6 Forty-nine samples were retrospectively re-analyzed with B1 qPCR in this work, thus it was essential 148 to verify that long-term storage at -20°C after initial diagnosis had not altered DNA. The mean Ct of 149 REP-529 qPCR obtained on samples before (at time of diagnosis) and after storage were similar (31.9 150 ± 0.8 versus 32.1 ± 0.8, p=0.8347). Additionally, the Ct results were compared using a Wilcoxon 151 paired test, which confirmed that they did not differ (p = 0.1631, data not shown), thus making 152 possible the interpretation of the data. 153
154
Comparison of B1 qPCR vs REP529 qPCR 155
The performance of both qPCR targets was analyzed on 76 samples. Overall, 31 of 69 extracts (45%) 156 tested positive with REP-529 qPCR were not amplified by the B1 qPCR, thus the relative sensitivity of 157 the B1 qPCR was 55%, compared to the REP-529 qPCR (Table 2 ). Seven false negative results (7 158 placenta samples) were also observed with REP-529; none was positive with the B1 qPCR. Thus, over 159 the study period, the absolute sensitivity of REP-529 qPCR and B1 qPCR on placenta samples was 160 80% and 37%, respectively (Tables 1&3). Their absolute specificity for prenatal diagnosis was 100% 161 and 90%, respectively (Table 3) . False negative results with the B1 qPCR, compared to REP-529 qPCR, 162
were observed on all sample types, yet mainly on placenta samples (15/28, 54%), blood samples 163 (6/7, 86%), and CSF (4/4, 100%) (Table 2) . Overall, the mean Ct obtained with REP-529 qPCR when B1 164 qPCR was negative was 36.84 ± 0.36 (corresponding to 0.37 ± 0.3 parasites/reaction), underlining the 165 need for a very sensitive qPCR assay. For the 38 samples which could be amplified with both qPCRs, 166 the mean Ct obtained with the B1 qPCR was significantly higher (+4.7 ± 0.3 Ct) than that obtained 167 with REP-529 qPCR (p<0.001) ( Table 4 ). The mean gain in amplification Ct ranged from 3.65 to 4.98 168 according to the type of sample, and was highly significant for amniotic fluids and placenta samples 169 (p<0.001, Table 4 ). The difference was not statistically significant for aqueous humor samples, 170 probably because of a lack of statistical power. 171
Regarding congenital toxoplasmosis, the B1 qPCR failed to amplify any of the available samples (AF, 172 PL or CB) in 11 out of 40 cases (27.5%) which were positive with REP-529 qPCR. This defect in 173 sensitivity would have had variable consequences according to the results of other biological 174 techniques used. Importantly, prenatal diagnosis would have been falsely negative in two cases (#19 175 and 31), and fetal infection would have remained unproven in a case of fetal loss (#17). Of note, B1 176 target also yielded a false negative result on the placenta sample from case #19 (Table 1 ). In three 177 other cases (#20, 26, 27), where no prenatal diagnosis had been performed because of late maternal 178 infection during the third trimester of pregnancy, the B1 qPCR would have left the newborns 179 undiagnosed, since no serological evidence of infection was observed until several months (Table 1) . 180
For the five remaining cases (#8, 11, 15, 22, 30), the consequences of the reduced sensitivity of B17 qPCR would have been negligible, as serological markers of congenital infection (specific IgM or IgA 182 detection, neosynthesized IgG on western-blots) were observed in newborns at birth or during the 183 first week of live. In case #15, B1 qPCR was falsely negative in both placenta and cord blood. In the 184 remaining cases, the lack of sensitivity of B1 on placenta samples was moot, since the diagnosis had 185 been made previously on AF. 186
Regarding ocular toxoplasmosis, one aqueous humor from an immunocompetent patient for whom 187
Western blot was not contributive, and one blood sample from a HIV+ patient, who did not undergo 188 aqueous humor puncture (Table 1) Toxoplasma is important, because it allows to eliminate other causes of spontaneous abortion and 230 avoids useless investigations. On the other hand, the positivity of prenatal diagnosis usually leads to 231 a change in chemotherapy, using pyrimethamine-sulfonamide combination therapy to treat the 232 mother (1-2), which would have been missed in the two B1-negative patients here. Finally, the 233 parasite DNA detection in placenta, even if not yet recognized as a standard criteria for the diagnosis 234 of congenital toxoplasmosis, was shown to have a positive predictive value over 90% in our hands 235 (6), and is at least a strong argument to accurately follow the infant and increase the frequency of 236 serologic testing to confirm infection, with the aim of reducing delay of treatment. We observed here 237 that parasite DNA detection from placenta was the earliest biological sign of infection in neonates 238 with neither IgM nor IgA detection, and recall the interest of this sample in patients for whom 239 antenatal diagnosis was negative or not performed. In 2 cases (#23, 41), both qPCR were negative on 240 placenta samples, whereas they were positive with mouse inoculation, still underlining the interest 241 to combine both techniques (Table 1) . 242
The B1 qPCR had also poor sensitivity in other clinical settings. The diagnosis of cerebral 243 toxoplasmosis is difficult, and ancient studies have reported a poor sensitivity of conventional PCR 244 methods (19-20), probably related to low parasite loads, but no recent studies evaluated new qPCR 245 methods in this setting. The present study was not designed to answer this question, but we noted 246 that four patients would have been undiagnosed using B1 qPCR. Besides, the REP-529 qPCR allowed 247 diagnosing two cases of chronic toxoplasmosis in patients with lymphadenopathy and history of 248
Toxoplasma seroconversion in the past twelve months, which led to consider this diagnosis and stop 249 further exploration aiming at diagnosing a hematological malignancy. 250
False negative results targeting B1 had a C t > 34 (mean 36.84 ± 0.36). This poor performance of B1 251 qPCR could be related to low parasite loads, a frequently observed situation in congenital 252 toxoplasmosis, particularly in France where women are treated all along pregnancy, which probably 253 decreases the parasite burden. In the study by Romand et al. (21) , 88 positive AF were included, of 254 which 35 (40%) were shown to contain less than 10 parasite/mL. 255
Besides, the proportion of undetected samples with the B1 qPCR was high for placenta samples (57% 256 of REP-529-positive samples) and blood samples (50%). In 12 placenta samples, B1 qPCR was 257 negative whereas mouse inoculation was positive, which is unusual. Poor sensitivity on blood and 258 placenta samples suggests that inhibitors would more likely interfere with this PCR. 
